Covid-19

Segurança comparativa das vacinas BNT162b2 e mRNA-1273 em uma coorte nacional de veteranos nos EUA.

19 Jun, 2022 | 14:27h

Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans – JAMA Internal Medicine

Comentário: Few differences in safety profiles of Moderna, Pfizer COVID-19 vaccines – Harvard T.H. Chan School of Public Health

 

Comentário no Twitter

1/
TODAY: We compared the safety of #COVID19 mRNA vaccines in the largest healthcare system in the US.

TAKE-HOME MESSAGE: Both Moderna and Pfizer vaccines are quite safe. If interested in vaccination, you can confidently use whichever one is available.https://t.co/fFIlXwH5Qv

— Miguel Hernán (@_MiguelHernan) June 13, 2022

 

---

Breve resumo dos principais fatos atuais e recomendações | Linfadenopatia regional após vacinação contra COVID-19 em pacientes com ou sem suspeita de câncer de mama.

19 Jun, 2022 | 14:21h

Regional Lymphadenopathy Following COVID-19 Vaccination in Patients with or Suspicious of Breast Cancer: A Quick Summary of Current Key Facts and Recommendations – Korean Journal of Radiology

Conteúdos relacionados:

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) – Insights into Imaging

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance – The BMJ

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination – European Radiology

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care – European Journal of Cancer

---

Diretriz atualizada NIH | Oxigenação e ventilação para adultos com Covid-19.

19 Jun, 2022 | 13:37h

Oxygenation and Ventilation for Adults – National Institutes of Health

---

M-A | Coinfecções respiratórias virais em pacientes com COVID-19 e desfechos associados.

19 Jun, 2022 | 13:34h

Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis – Reviews in Medical Virology

---

Estudo randomizado | Tixagevimabe-cilgavimabe intramuscular pode ser benéfico para adultos não vacinados e não internados com Covid-19.

19 Jun, 2022 | 13:33h

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial – The Lancet Respiratory Medicine

Comentários:

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID – News Medical

Expert reaction to results of the TACKLE Phase 3 trial of Evusheld (tixagevimab and cilgavimab) for treating early COVID-19 in outpatients – Science Media Centre

 

Comentário no Twitter

NEW—A single intramuscular tixagevimab–cilgavimab dose provided protection against progression to severe COVID-19 or death vs placebo in unvaccinated individuals

TACKLE trial from Prof Hugh Montgomery & colleagues https://t.co/M9LENFsA2C pic.twitter.com/Aon4wJsBOi

— The Lancet Respiratory Medicine (@LancetRespirMed) June 8, 2022

 

---

Outro estudo sugere que a variante Ômicron está associada com risco reduzido de síndrome inflamatória multissistêmica em crianças em comparação a variantes anteriores do SARS-CoV-2.

16 Jun, 2022 | 14:01h

Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave – JAMA Pediatrics

Estudo relacionado: Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel – JAMA E Commentary: Kids’ COVID syndrome—MIS-C—less severe in Omicron – CIDRAP

 

Comentário no Twitter

Study found that the risk of multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection during the #Omicron wave substantially lower compared to previous #SARSCoV2 variants. https://t.co/GYrz9XA72Z

— JAMA Pediatrics (@JAMAPediatrics) June 8, 2022

 

---

Estudo de coorte | Desfechos de neurodesenvolvimento em 1 ano em bebês de mães com teste positivo para SARS-CoV-2 durante a gestação.

16 Jun, 2022 | 13:58h

Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During Pregnancy – JAMA Network Open

Comentários:

Is It Exposure to the Pandemic or to Maternal SARS-CoV-2 Infection That Is Adversely Affecting Early Childhood Neurodevelopment? – JAMA Network Open

Expert reaction to observational study of mothers who tested positive for SARS-CoV-2 during pregnancy and neurodevelopmental outcomes in their children at 1 year – Science Media Centre

 

Comentário no Twitter

This cohort study of #SARSCoV2 exposure in utero found preliminary evidence that maternal SARS-CoV-2 may be associated with neurodevelopmental sequelae in some offspring. https://t.co/dYdoJbNOdl

— JAMA Network Open (@JAMANetworkOpen) June 9, 2022

 

---

M-A | Ocorrência e potencial de transmissão de infecções por SARS-CoV-2 assintomáticas e pré-sintomáticas.

16 Jun, 2022 | 13:55h

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis – PLOS Medicine

---

Diretriz | Triagem e momento cirúrgicos em pacientes com COVID submetidos a cirurgia torácica.

16 Jun, 2022 | 13:54h

Surgical Triage and Timing for Patients with COVID: A Guidance Statement from the Society of Thoracic Surgeons – Annals of Thoracic Surgery

---

Revisão | Fisiopatologia e mecanismo da COVID longa.

16 Jun, 2022 | 13:52h

Pathophysiology and mechanism of long COVID: a comprehensive review – Annals of Medicine

---